PEPTAS stock materials
Stock Peptides and Research Materials
A small held inventory of identified research materials, supplied by Ikigai Corporation Limited under Hong Kong law and quoted on request. Materials outside this list are supplied through custom synthesis or volume supply.
Why a quotation, and not a price.
PEPTAS quotes every order in writing. What a material costs depends on the quantity, the pack format, the documentation you need and where it is going, and each complete request is reviewed before a quotation is issued. Tell us the material and the quantity, and after review PEPTAS may issue a written quotation covering price, availability, documentation and delivery basis, request further information or decline the request. If something is missing we ask before we quote.
| Material | Catalog ID | Pack formats held | Molecular class | Form | Availability | Action |
|---|---|---|---|---|---|---|
| BPC-157 5mg | PEP-BPC157-005 | 5 mg | Linear peptides | Lyophilized powder | In stock | Request a quotation |
| Cagrilintide 10mg | PEP-CAGRI-010 | 10 mg | Fatty-acid-modified peptide analogues | Lyophilized powder | In stock | Request a quotation |
| GHRP-2 5mg | PEP-GHRP2-005 | 5 mg | Linear peptides | Lyophilized powder | In stock | Request a quotation |
| GHRP-6 5mg | PEP-GHRP6-005 | 5 mg | Linear peptides | Lyophilized powder | In stock | Request a quotation |
| Hexarelin 5mg | PEP-HEXARELIN-005 | 5 mg | Linear peptides | Lyophilized powder | In stock | Request a quotation |
| hGH Fragment 176-191 6mg | PEP-HGH176191-006 | 6 mg | Cyclic and disulfide-bridged peptides | Lyophilized powder | In stock | Request a quotation |
| Humanin 10mg | PEP-HUMANIN-010 | 10 mg | Linear peptides | Lyophilized powder | In stock | Request a quotation |
| Kisspeptin-10 10mg | PEP-KISS10-010 | 10 mg | Linear peptides | Lyophilized powder | In stock | Request a quotation |
| LL-37 5mg | PEP-LL37-005 | 5 mg | Linear peptides | Lyophilized powder | In stock | Request a quotation |
| Melanotan 2 (MT2) 20mg | PEP-MT2-020 | 20 mg | Cyclic and disulfide-bridged peptides | Lyophilized powder | In stock | Request a quotation |
| NAD+ 500mg | RM-NADPLUS-500 | 500 mg | Nucleotide coenzymes | Lyophilized powder (dinucleotide coenzyme, not a peptide) | In stock | Request a quotation |
| PT-141 10mg | PEP-PT141-010 | 10 mg | Cyclic and disulfide-bridged peptides | Lyophilized powder | In stock | Request a quotation |
| Retatrutide 16mg | PEP-RETATRUTIDE-016 | 16 mg | Fatty-acid-modified peptide analogues | Lyophilized powder | In stock | Request a quotation |
| Selank 10mg | PEP-SELANK-010 | 10 mg | Linear peptides | Lyophilized powder | In stock | Request a quotation |
| Sermorelin 5mg | PEP-SERMORELIN-005 | 5 mg | Linear peptides | Lyophilized powder | In stock | Request a quotation |
| Tesamorelin 2mg | PEP-TESAMORELIN-002 | 2 mg | Linear peptides | Lyophilized powder | In stock | Request a quotation |
| Tirzepatide 5mg | PEP-TIRZEPATIDE-005 | 5 mg | Fatty-acid-modified peptide analogues | Lyophilized powder | In stock | Request a quotation |
Reference catalog
The reference list below names materials that can be quoted on request. Entries marked In stock are the held inventory shown above.
Species in a name (human, rat, bovine, ovine, salmon) identifies the sequence the material is based on, not an intended use.
Modified and analogue peptides not classifiable above
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| 3xFLAG peptide | PEP-MOD-0001 | 402750-12-3 | — | — | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Ac-SDKP (goralatide) | PEP-MOD-0002 | 120081-14-3 | C20H33N5O9 | 487.5 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Acetyl hexapeptide-8 | PEP-MOD-0003 | 616204-22-9 | C35H62N14O11S | 887.0 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Anserine | PEP-MOD-0004 | 584-85-0 | C10H16N4O3 | 240.3 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Aspartame-related dipeptide H-Asp-Phe-OMe | PEP-MOD-0005 | — | C14H18N2O5 | 294.3 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| BPC-157 | PEP-MOD-0006 | 137525-51-0 | C62H98N16O22 | 1419.6 | — | — | Modified and analogue peptides not classifiable above | In stock | Request a quotation |
| Carnosine | PEP-MOD-0007 | 305-84-0 | C9H14N4O3 | 226.2 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Cortagen | PEP-MOD-0008 | 335591-03-2 | C17H26N4O9 | 430.4 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Epitalon | PEP-MOD-0009 | — | C14H22N4O9 | 390.4 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| GHK tripeptide | PEP-MOD-0010 | — | C14H24N6O4 | 340.4 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Glutathione (reduced) | PEP-MOD-0011 | — | C10H17N3O6S | 307.3 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Glycyl-L-glutamine | PEP-MOD-0012 | 13115-71-4 | C7H13N3O4 | 203.2 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Homocarnosine | PEP-MOD-0013 | 3650-73-5 | C10H16N4O3 | 240.3 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| L-Alanyl-L-glutamine | PEP-MOD-0014 | — | C8H15N3O4 | 217.2 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Livagen | PEP-MOD-0015 | 433257-50-2 | C18H31N5O9 | 461.5 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Palmitoyl pentapeptide-4 | PEP-MOD-0016 | 214047-00-4 | C39H75N7O10 | 802.1 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Peptide E (bovine) | PEP-MOD-0017 | 78355-50-7 | C147H207N41O34S2 | 3156.6 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Pinealon | PEP-MOD-0018 | 175175-23-2 | C15H26N6O8 | 418.4 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
| Vilon | PEP-MOD-0019 | 45234-02-4 | C11H21N3O5 | 275.3 | — | — | Modified and analogue peptides not classifiable above | Quotation on request | Request a quotation |
Vasoactive peptides
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| [des-Arg9]-Bradykinin | PEP-VAS-0001 | 15958-92-6 | C44H61N11O10 | 904.0 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| [Hyp3]-Bradykinin | PEP-VAS-0002 | 37642-65-2 | C50H73N15O12 | 1076.2 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| [Sar1, Ile8]-Angiotensin II | PEP-VAS-0003 | 37827-06-8 | C46H73N13O10 | 968.2 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Adrenomedullin (human) | PEP-VAS-0004 | 148498-78-6 | C264H406N80O77S3 | 6029.0 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Angiotensin (1-5) | PEP-VAS-0005 | 58442-64-1 | C30H48N8O9 | 664.8 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Angiotensin (1-7) | PEP-VAS-0006 | — | C41H62N12O11 | 899.0 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Angiotensin (1-9) | PEP-VAS-0007 | 34273-12-6 | C56H78N16O13 | 1183.3 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Angiotensin I (human) | PEP-VAS-0008 | — | C62H89N17O14 | 1296.5 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Angiotensin II (human) | PEP-VAS-0009 | 4474-91-3 | C50H71N13O12 | 1046.2 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Angiotensin III | PEP-VAS-0010 | — | C46H66N12O9 | 931.1 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Angiotensin IV | PEP-VAS-0011 | — | C40H54N8O8 | 774.9 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Angiotensinogen (1-14) human | PEP-VAS-0012 | 104180-23-6 | C83H122N24O19 | 1760.0 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Apelin-13 | PEP-VAS-0013 | 217082-58-1 | C69H111N23O16S | 1550.8 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Apelin-17 | PEP-VAS-0014 | — | C96H156N34O20S | 2138.6 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Apelin-36 | PEP-VAS-0015 | 230299-95-3 | C185H304N68O43S | 4201.0 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Atrial natriuretic peptide (1-28) human | FRG-VAS-0001 | — | — | — | P01160 | precursor 124-151 (ANP residues 1-28) | Vasoactive peptides | Quotation on request | Request a quotation |
| Big endothelin-1 (1-38) human | FRG-VAS-0002 | — | — | — | P05305 | precursor 53-90 (Big endothelin-1 residues 1-38) | Vasoactive peptides | Quotation on request | Request a quotation |
| BQ-123 | PEP-VAS-0016 | — | C31H42N6O7 | 610.7 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| BQ-788 | PEP-VAS-0017 | 156161-89-6 | C34H50N5NaO7 | 663.8 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Bradykinin | PEP-VAS-0018 | 58-82-2 | C50H73N15O11 | 1060.2 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Brain natriuretic peptide (1-32) human | PEP-VAS-0019 | — | C143H244N50O42S4 | 3464.0 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| CNP-22 (human) | FRG-VAS-0003 | — | — | — | P23582 | 105-126 | Vasoactive peptides | Quotation on request | Request a quotation |
| CNP-53 (human) | FRG-VAS-0004 | — | — | — | P23582 | 74-126 | Vasoactive peptides | Quotation on request | Request a quotation |
| Elabela (Toddler) peptide | FRG-VAS-0005 | — | — | — | P0DMC3 | 23-54 | Vasoactive peptides | Quotation on request | Request a quotation |
| Endothelin-1 (human) | PEP-VAS-0020 | — | C109H159N25O32S5 | 2491.9 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Endothelin-2 (human) | PEP-VAS-0021 | — | C115H160N26O32S4 | 2546.9 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Endothelin-3 (human) | PEP-VAS-0022 | — | C121H168N26O33S4 | 2643.1 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Icatibant | PEP-VAS-0023 | 130308-48-4 | C59H89N19O13S | 1304.5 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Intermedin (adrenomedullin 2) | FRG-VAS-0006 | — | — | — | Q7Z4H4 | 101-147 | Vasoactive peptides | Quotation on request | Request a quotation |
| Kallidin (Lys-bradykinin) | PEP-VAS-0024 | 342-10-9 | C56H85N17O12 | 1188.4 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Neurotensin | PEP-VAS-0025 | — | C78H121N21O20 | 1672.9 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Neurotensin (8-13) | PEP-VAS-0026 | 60482-95-3 | C38H64N12O8 | 817.0 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| NT-proBNP (1-76) human | FRG-VAS-0007 | — | — | — | P16860 | precursor 27-102 (NT-proBNP residues 1-76) | Vasoactive peptides | Quotation on request | Request a quotation |
| Proadrenomedullin N-terminal 20 peptide | FRG-VAS-0008 | — | — | — | P35318 | 22-41 | Vasoactive peptides | Quotation on request | Request a quotation |
| Pyr-apelin-13 | PEP-VAS-0027 | 217082-60-5 | C69H108N22O16S | 1533.8 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Urodilatin | PEP-VAS-0028 | — | C145H234N52O44S3 | 3505.9 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Urotensin II (human) | PEP-VAS-0029 | 9047-55-6 | C64H85N13O18S2 | 1388.6 | — | — | Vasoactive peptides | Quotation on request | Request a quotation |
| Vasostatin-1 | FRG-VAS-0009 | — | — | — | P10645 | 19-94 | Vasoactive peptides | Quotation on request | Request a quotation |
Peptide hormones and receptor ligands
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| Abaloparatide | PEP-GPR-0001 | 247062-33-5 | C174H300N56O49 | 3961.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Abarelix | PEP-GPR-0002 | 183552-38-7 | C72H95ClN14O14 | 1416.1 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| ACTH (1-24) | PEP-GPR-0003 | 16960-16-0 | C136H210N40O31S | 2933.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| ACTH (1-39) human | FRG-GPR-0001 | — | — | — | P01189 | precursor 138-176 (ACTH residues 1-39) | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| ACTH (4-10) | PEP-GPR-0004 | 4037-01-8 | C44H59N13O10S | 962.1 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| ACTH (7-38) | PEP-GPR-0005 | 68563-24-6 | C167H257N47O46 | 3659.1 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Adiponectin globular domain (human, recombinant) | FRG-GPR-0002 | — | — | — | Q15848 | 108-244 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Adropin (34-76) | PEP-GPR-0006 | — | C190H293N55O68S2 | 4500.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Albiglutide | PEP-GPR-0007 | 782500-75-8 | C148H223N39O46 | 3284.6 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| alpha-MSH | PEP-GPR-0008 | 581-05-5 | C77H109N21O19S | 1664.9 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Amylin (human) | PEP-GPR-0009 | 122384-88-7 | C165H261N51O55S2 | 3903.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Anamorelin | PEP-GPR-0010 | 249921-19-5 | C31H42N6O3 | 546.7 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Arginine vasopressin | PEP-GPR-0011 | 113-79-1 | C46H65N15O12S2 | 1084.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Astressin | PEP-GPR-0012 | — | C161H269N49O42 | 3563.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Atosiban | PEP-GPR-0013 | 90779-69-4 | C43H67N11O12S2 | 994.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| beta-MSH (human) | PEP-GPR-0014 | 9034-42-8 | C118H174N34O35S | 2660.9 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Big gastrin (17-34) | PEP-GPR-0015 | — | C132H194N40O49S | 3157.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Bombesin | PEP-GPR-0016 | 31362-50-2 | C71H110N24O18S | 1619.9 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Bombesin (8-14) | PEP-GPR-0017 | 55749-98-9 | C38H57N11O7S | 812.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Buserelin | PEP-GPR-0018 | 57982-77-1 | C60H86N16O13 | 1239.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| C-peptide (human) | PEP-GPR-0019 | 33017-11-7 | C129H211N35O48 | 3020.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Cagrilintide | PEP-GPR-0020 | 1415456-99-3 | C194H312N54O59S2·xC2H4O2 | 4409.1 | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| Calcitonin (human) | PEP-GPR-0021 | 21215-62-3 | C151H226N40O45S3 | 3417.9 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Calcitonin (salmon) | PEP-GPR-0022 | 135506-95-5 | C145H240N44O48S2 | 3431.9 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Carbetocin | PEP-GPR-0023 | 37025-55-1 | C45H69N11O12S | 988.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Cetrorelix | PEP-GPR-0024 | 120287-85-6 | C70H92ClN17O14 | 1431.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| CGRP (alpha, human) | FRG-GPR-0003 | — | — | — | P06881 | 83-119 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| CGRP (beta, human) | FRG-GPR-0004 | — | — | — | P10092 | 82-118 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Cholecystokinin octapeptide (CCK-8) | PEP-GPR-0025 | — | C49H62N10O16S3 | 1143.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Cholecystokinin tetrapeptide (CCK-4) | PEP-GPR-0026 | — | C29H36N6O6S | 596.7 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| CJC-1295 | PEP-GPR-0027 | 446262-90-4 | C165H269N47O46 | 3647.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| CJC-1295 with DAC | PEP-GPR-0028 | — | C152H252N44O42 | 3367.9 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Corticorelin (CRH, human) | FRG-GPR-0005 | — | — | — | P06850 | 154-194 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Corticotropin-releasing factor (6-33) human | PEP-GPR-0029 | — | C141H231N41O43S | 3220.7 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Degarelix | PEP-GPR-0030 | 214766-78-6 | C82H103ClN18O16 | 1632.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Des-acyl ghrelin (human) | PEP-GPR-0031 | — | C141H235N47O41 | 3244.7 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Deslorelin | PEP-GPR-0032 | 57773-65-6 | C64H83N17O12 | 1282.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Desmopressin | PEP-GPR-0033 | 16679-58-6 | C46H64N14O12S2 | 1069.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Dulaglutide | PEP-GPR-0034 | 1197810-60-8 | C149H221N37O49 | 3314.6 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Elcatonin | PEP-GPR-0035 | 60731-46-6 | C148H244N42O47 | 3363.8 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Exenatide | PEP-GPR-0036 | 141758-74-9 | C184H282N50O60S | 4187.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Exendin (9-39) | PEP-GPR-0037 | 133514-43-9 | C149H234N40O47S | 3369.8 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Exendin-4 | PEP-GPR-0038 | — | C184H282N50O60S | 4187.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Felypressin | PEP-GPR-0039 | 56-59-7 | C46H65N13O11S2 | 1040.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| gamma-1-MSH | FRG-GPR-0006 | — | — | — | P01189 | 77-87 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Ganirelix | PEP-GPR-0040 | 124904-93-4 | C80H113ClN18O13 | 1570.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Gastrin I (human) | PEP-GPR-0041 | — | C97H124N20O31S | 2098.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Gastrin-releasing peptide (human) | FRG-GPR-0007 | — | — | — | P07492 | 24-50 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Ghrelin (human, acylated) | FRG-GPR-0008 | — | — | — | Q9UBU3 | 24-51 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Ghrelin (rat) | PEP-GPR-0042 | — | C149H249N47O42 | 3370.9 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| GHRH (1-44) amide human | FRG-GPR-0009 | — | — | — | P01286 | 32-75 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| GHRP-1 | PEP-GPR-0043 | 141925-59-9 | C51H62N12O7 | 955.1 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| GHRP-2 | PEP-GPR-0044 | 158861-67-7 | C45H55N9O6 | 818.0 | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| GHRP-6 | PEP-GPR-0045 | 87616-84-0 | C46H56N12O6 | 873.0 | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| GIP (1-42) human | FRG-GPR-0010 | — | — | — | P09681 | precursor 52-93 (GIP residues 1-42) | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| GIP (3-42) | FRG-GPR-0011 | — | — | — | P09681 | precursor 54-93 (GIP residues 3-42) | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| GLP-1 (7-37) | PEP-GPR-0046 | 106612-94-6 | C151H228N40O47 | 3355.7 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| GLP-2 (human) | PEP-GPR-0047 | 223460-79-5 | C165H254N44O55S | 3766.1 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Glucagon (human) | PEP-GPR-0048 | 9007-92-5 | C153H225N43O49S | 3482.7 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Gonadorelin (GnRH) | PEP-GPR-0049 | 33515-09-2 | C55H75N17O13 | 1182.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Gonadotropin-releasing hormone associated peptide (GAP) | FRG-GPR-0012 | — | — | — | P01148 | 37-92 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Goserelin | PEP-GPR-0050 | 65807-02-5 | C59H84N18O14 | 1269.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Hexarelin | PEP-GPR-0051 | 140703-51-1 | C47H58N12O6 | 887.1 | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| hGH Fragment 176-191 | PEP-GPR-0052 | 66004-57-7 | C78H123N23O22S2 | 1799.1 | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| Histrelin | PEP-GPR-0053 | 76712-82-8 | C66H86N18O12 | 1323.5 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Human chorionic gonadotropin beta (109-145) | FRG-GPR-0013 | — | — | — | P0DN86 | 109-145 (mature-chain numbering; UniProt precursor positions 129-165) | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| INSL3 (human) | PRO-GPR-0001 | — | — | — | P51460 | 131 aa | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| INSL5 (human) | PRO-GPR-0002 | — | — | — | Q9Y5Q6 | 135 aa | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Insulin (human, recombinant) | PEP-GPR-0054 | 9004-10-8 | C256H381N65O77S6 | 5794.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Insulin aspart | PEP-GPR-0055 | 116094-23-6 | C256H387N65O79S6 | 5832.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Insulin degludec | PEP-GPR-0056 | 844439-96-9 | C274H411N65O81S6 | 6104.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Insulin detemir | PEP-GPR-0057 | 169148-63-4 | C267H402N64O76S6 | 5917.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Insulin glargine | PEP-GPR-0058 | 160337-95-1 | C267H404N72O78S6 | 6063.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Insulin lispro | PEP-GPR-0059 | 133107-64-9 | C257H389N65O77S6 | 5814.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Ipamorelin | PEP-GPR-0060 | 170851-70-4 | C38H49N9O5 | 711.9 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Katacalcin | PEP-GPR-0061 | 85916-47-8 | C97H154N34O36S2 | 2436.6 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Kisspeptin-10 | PEP-GPR-0062 | 374675-21-5 | C63H83N17O14 | 1302.5 | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| Kisspeptin-54 | FRG-GPR-0014 | — | — | — | Q15726 | 68-121 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Lanreotide | PEP-GPR-0063 | 108736-35-2 | C54H69N11O10S2 | 1096.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Leptin fragment (116-130) | FRG-GPR-0015 | — | — | — | P41159 | 116-130 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Leuprolide | PEP-GPR-0064 | 53714-56-0 | C59H84N16O12 | 1209.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Liraglutide | PEP-GPR-0065 | 204656-20-2 | C172H265N43O51 | 3751.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Lixisenatide | PEP-GPR-0066 | 320367-13-3 | C215H347N61O65S | 4858.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Lypressin | PEP-GPR-0067 | 50-57-7 | C46H65N13O12S2 | 1056.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Macimorelin | PEP-GPR-0068 | 381231-18-1 | C26H30N6O3 | 474.6 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Melanin-concentrating hormone (human) | PEP-GPR-0069 | — | C105H160N30O26S4 | 2386.8 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Melanocyte-stimulating hormone release-inhibiting factor (MIF-1) | PEP-GPR-0070 | 9083-38-9 | C13H24N4O3 | 284.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Melanotan-1 (afamelanotide) | PEP-GPR-0071 | 75921-69-6 | C78H111N21O19 | 1646.8 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Melanotan-2 | PEP-GPR-0072 | 121062-08-6 | C50H69N15O9 | 1024.2 | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| Motilin (human) | PEP-GPR-0073 | — | C120H188N34O35S | 2699.1 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Nafarelin | PEP-GPR-0074 | 76932-56-4 | C66H83N17O13 | 1322.5 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Neuromedin B | PEP-GPR-0075 | 87096-84-2 | C52H73N15O12S | 1132.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Neuromedin C | PEP-GPR-0076 | 81608-30-2 | C50H73N17O11S | 1120.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Neuromedin N | PEP-GPR-0077 | 102577-25-3 | C38H63N7O8 | 745.9 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Neuromedin S (human) | FRG-GPR-0016 | — | — | — | Q5H8A3 | 109-141 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Neuromedin U-25 (human) | FRG-GPR-0017 | — | — | — | P48645 | 142-166 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Neuromedin U-8 | PEP-GPR-0078 | 98530-27-9 | C50H76N16O11 | 1077.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Octreotide | PEP-GPR-0079 | 83150-76-9 | C49H66N10O10S2 | 1019.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Ornipressin | PEP-GPR-0080 | 3397-23-7 | C45H63N13O12S2 | 1042.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Osteostatin PTHrP (107-111) | PEP-GPR-0081 | — | C27H41N9O8 | 619.7 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Oxyntomodulin | PEP-GPR-0082 | 62340-29-8 | C192H295N59O60S | 4422.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Oxytocin | PEP-GPR-0083 | 50-56-6 | C43H66N12O12S2 | 1007.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Pancreastatin (human) | PEP-GPR-0084 | — | C214H330N68O76S | 5103.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Pancreatic polypeptide (human) | FRG-GPR-0018 | — | — | — | P01298 | 30-65 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Parathyroid hormone (1-84) human | FRG-GPR-0019 | — | — | — | P01270 | 32-115 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Pasireotide | PEP-GPR-0085 | 396091-73-9 | C58H66N10O9 | 1047.2 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Peptide YY (1-36) human | FRG-GPR-0020 | — | — | — | P10082 | 29-64 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Peptide YY (3-36) human | FRG-GPR-0021 | — | — | — | P10082 | 31-64 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Pramlintide | PEP-GPR-0086 | 151126-32-8 | C171H267N51O53S2 | 3949.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Proinsulin (human) | FRG-GPR-0022 | — | — | — | P01308 | 25-110 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Prolactin-releasing peptide (31) human | FRG-GPR-0023 | — | — | — | P81277 | 23-53 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Protirelin (TRH) | PEP-GPR-0087 | 24305-27-9 | C16H22N6O4 | 362.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| PT-141 (bremelanotide) | PEP-GPR-0088 | 189691-06-3 | C50H68N14O10 | 1025.2 | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| PTHrP (1-34) human | FRG-GPR-0024 | — | — | — | P12272 | precursor 37-70 (PTHrP residues 1-34) | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Relaxin-2 (human, recombinant) | FRG-GPR-0025 | — | — | — | P04090 | B chain 25-53, A chain 162-185 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Relaxin-3 (human) | PRO-GPR-0003 | — | — | — | Q8WXF3 | 142 aa | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Retatrutide | PEP-GPR-0089 | 2381089-83-2 | C223H343F3N46O70 | 4845.4 | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| Saralasin | PEP-GPR-0090 | 34273-10-4 | C42H65N13O10 | 912.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Secretin (human) | PEP-GPR-0091 | — | C130H219N43O42 | 3056.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Semaglutide | PEP-GPR-0092 | 910463-68-2 | C187H291N45O59 | 4114.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Sermorelin | PEP-GPR-0093 | 86168-78-7 | C149H246N44O42S | 3357.9 | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| Setmelanotide | PEP-GPR-0094 | 920014-72-8 | C49H68N18O9S2 | 1117.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Somatostatin-14 | PEP-GPR-0095 | 38916-34-6 | C76H104N18O19S2 | 1637.9 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Somatostatin-28 | PEP-GPR-0096 | 73032-94-7 | C137H207N41O39S3 | 3148.6 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Teduglutide | PEP-GPR-0097 | 197922-42-2 | C164H252N44O55S | 3752.1 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Teriparatide | PEP-GPR-0098 | 52232-67-4 | C181H291N55O51S2 | 4118.0 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Terlipressin | PEP-GPR-0099 | 14636-12-5 | C52H74N16O15S2 | 1227.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Tesamorelin | PEP-GPR-0100 | 901758-09-6 | — | — | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| Tirzepatide | PEP-GPR-0101 | 2023788-19-2 | C225H348N48O68 | 4813.5 | — | — | Peptide hormones and receptor ligands | In stock | Request a quotation |
| TRH-Gly | PEP-GPR-0102 | 85344-77-0 | C18H24N6O6 | 420.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Triptorelin | PEP-GPR-0103 | 57773-63-4 | C64H82N18O13 | 1311.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Urantide | PEP-GPR-0104 | 669089-53-6 | C51H66N10O12S2 | 1075.3 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Urocortin 1 (human) | FRG-GPR-0026 | — | — | — | P55089 | 83-122 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Urocortin 2 (human) | FRG-GPR-0027 | — | — | — | Q96RP3 | 72-112 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Urocortin 3 (human) | FRG-GPR-0028 | — | — | — | Q969E3 | 120-157 | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Vapreotide | PEP-GPR-0105 | 103222-11-3 | C57H70N12O9S2 | 1131.4 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
| Xenin-25 | PEP-GPR-0106 | 144092-28-4 | C139H224N38O32S | 2971.6 | — | — | Peptide hormones and receptor ligands | Quotation on request | Request a quotation |
Protease inhibitors and peptidic inhibitors
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| Ac-DEVD-CHO | PEP-INH-0001 | — | C20H30N4O11 | 502.5 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Alpha-1 antitrypsin (human) | PRO-INH-0001 | — | — | — | P01009 | 418 aa | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Amastatin | PEP-INH-0002 | 67655-94-1 | C21H38N4O8 | 474.5 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Antipain | PEP-INH-0003 | — | C27H44N10O6 | 604.7 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Aprotinin | PEP-INH-0004 | 9087-70-1 | C284H432N84O79S7 | 6511.0 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Bestatin | PEP-INH-0005 | 58970-76-6 | C16H24N2O4 | 308.4 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Bivalirudin | PEP-INH-0006 | — | C98H138N24O33 | 2180.3 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Bortezomib | PEP-INH-0007 | — | C19H25BN4O4 | 384.2 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Calpain inhibitor I (ALLN) | PEP-INH-0008 | — | C20H37N3O4 | 383.5 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Calpain inhibitor II (ALLM) | PEP-INH-0009 | — | C19H35N3O4S | 401.6 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Carfilzomib | PEP-INH-0010 | 868540-17-4 | C40H57N5O7 | 719.9 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Chymostatin | PEP-INH-0011 | — | C31H41N7O6 | 607.7 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Cystatin C (human, recombinant) | PRO-INH-0002 | — | — | — | P01034 | 146 aa | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| E-64 protease inhibitor | PEP-INH-0012 | — | C15H27N5O5 | 357.4 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Elastatinal | PEP-INH-0013 | 51798-45-9 | C21H36N8O7 | 512.6 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Epoxomicin | PEP-INH-0014 | 134381-21-8 | C28H50N4O7 | 554.7 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Hirudin (recombinant) | PRO-INH-0003 | — | — | — | P01050 | 65 aa | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Leupeptin | PEP-INH-0015 | — | C20H38N6O4 | 426.6 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| MG-132 (Z-Leu-Leu-Leu-al) | PEP-INH-0016 | — | C26H41N3O5 | 475.6 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Obestatin (human) | PEP-INH-0017 | 1081110-72-6 | C116H176N32O33 | 2546.8 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Pepstatin A | PEP-INH-0018 | — | C34H63N5O9 | 685.9 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Phosphoramidon | PEP-INH-0019 | 36357-77-4 | C23H34N3O10P | 543.5 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Q-VD-OPh | PEP-INH-0020 | 1135695-98-5 | C26H25F2N3O6 | 513.5 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Soybean trypsin inhibitor | PRO-INH-0004 | — | — | — | P01070 | 216 aa | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| TIMP-1 (human, recombinant) | PRO-INH-0005 | — | — | — | P01033 | 207 aa | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
| Z-VAD-FMK | PEP-INH-0021 | 187389-52-2 | C22H30FN3O7 | 467.5 | — | — | Protease inhibitors and peptidic inhibitors | Quotation on request | Request a quotation |
Protease substrates and chromogenic/fluorogenic peptides
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| ACE substrate Hip-His-Leu | PEP-SUB-0001 | 31373-65-6 | C21H27N5O5 | 429.5 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Caspase-1 substrate Ac-YVAD-AMC | PEP-SUB-0002 | 149231-65-2 | C33H39N5O10 | 665.7 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Caspase-3 substrate Ac-DEVD-AMC | PEP-SUB-0003 | 169332-61-0 | C30H37N5O13 | 675.6 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Caspase-6 substrate Ac-VEID-AMC | PEP-SUB-0004 | 219137-97-0 | C32H43N5O11 | 673.7 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Caspase-8 substrate Ac-IETD-AMC | PEP-SUB-0005 | 348079-17-4 | C31H41N5O12 | 675.7 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Caspase-9 substrate Ac-LEHD-AMC | PEP-SUB-0006 | 292633-16-0 | C33H41N7O11 | 711.7 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Cathepsin B substrate Z-Arg-Arg-AMC | PEP-SUB-0007 | 88937-61-5 | C30H39N9O6 | 621.7 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Cathepsin K substrate Z-Leu-Arg-AMC | PEP-SUB-0008 | 156192-32-4 | C30H38N6O6 | 578.7 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Elastase substrate Suc-Ala-Ala-Pro-Val-pNA | PEP-SUB-0009 | 72682-76-9 | C26H36N6O9 | 576.6 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Factor Xa substrate Bz-Ile-Glu-Gly-Arg-pNA | PEP-SUB-0010 | 60457-00-3 | C32H44ClN9O9 | 734.2 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Furin substrate Pyr-Arg-Thr-Lys-Arg-AMC | PEP-SUB-0011 | 155575-02-3 | C37H57N13O9 | 827.9 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Plasmin substrate H-D-Val-Leu-Lys-pNA | PEP-SUB-0012 | 63589-93-5 | C23H38N6O5 | 478.6 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Proteasome substrate Suc-Leu-Leu-Val-Tyr-AMC | PEP-SUB-0013 | 94367-21-2 | C40H53N5O10 | 763.9 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Proteasome substrate Z-Leu-Leu-Glu-AMC | PEP-SUB-0014 | 348086-66-8 | C35H44N4O9 | 664.7 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Renin substrate tetradecapeptide (porcine) | PEP-SUB-0015 | 20845-02-7 | C85H123N21O20 | 1759.0 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Thrombin substrate Boc-Val-Pro-Arg-AMC | PEP-SUB-0016 | — | C31H45N7O7 | 627.7 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Thrombin substrate Z-Gly-Gly-Arg-AMC | PEP-SUB-0017 | — | C28H33N7O7 | 579.6 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
| Trypsin-like substrate Boc-Leu-Arg-Arg-AMC | PEP-SUB-0018 | 109358-46-5 | C33H52N10O7 | 700.8 | — | — | Protease substrates and chromogenic/fluorogenic peptides | Quotation on request | Request a quotation |
Growth factors, cytokines and their fragments
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| Activin A (human, recombinant) | PRO-GFR-0001 | — | — | — | P08476 | 426 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| ARA-290 (cibinetide) | PEP-GFR-0001 | 1208243-50-8 | C51H84N16O21 | 1257.3 | — | — | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Brain-derived neurotrophic factor (human, recombinant) | PRO-GFR-0002 | — | — | — | P23560 | 247 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Chemerin-9 | PEP-GFR-0002 | — | C54H66N10O13 | 1063.2 | — | — | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Ciliary neurotrophic factor (human, recombinant) | PRO-GFR-0003 | — | — | — | P26992 | 372 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Epidermal growth factor (human, recombinant) | PEP-GFR-0003 | 62229-50-9 | C257H381N73O83S7 | 6046.0 | — | — | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Erythropoietin (human, recombinant) | PRO-GFR-0004 | — | — | — | P01588 | 193 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Fibroblast growth factor 1 (human, recombinant) | PRO-GFR-0005 | — | — | — | P61328 | 243 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Fibroblast growth factor 19 (human, recombinant) | PRO-GFR-0006 | — | — | — | O95750 | 216 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Fibroblast growth factor 2 (human, recombinant) | PRO-GFR-0007 | — | — | — | P09038 | 288 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Fibroblast growth factor 21 (human, recombinant) | PRO-GFR-0008 | — | — | — | Q9NSA1 | 209 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Follistatin (human, recombinant) | PRO-GFR-0009 | — | — | — | P19883 | 344 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Glial cell line-derived neurotrophic factor (human) | PRO-GFR-0010 | — | — | — | P39905 | 211 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Granulocyte-macrophage colony-stimulating factor (human, recombinant) | PRO-GFR-0011 | — | — | — | P04141 | 144 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Hepatocyte growth factor fragment NK1 | PRO-GFR-0012 | — | — | — | P14210 | 728 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| IGF-1 (human, recombinant) | FRG-GFR-0001 | — | — | — | P05019 | 49-118 | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| IGF-1 DES(1-3) | FRG-GFR-0002 | — | — | — | P05019 | precursor 52-118 (mature IGF-1 residues 4-70) | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| IGF-2 (human, recombinant) | FRG-GFR-0003 | — | — | — | P01344 | 25-91 | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Inhibin alpha (1-32) human | FRG-GFR-0004 | — | — | — | P05111 | 1-32 (mature inhibin-alpha-chain numbering; UniProt precursor positions 233-264) | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Interferon alpha-2b (human, recombinant) | PRO-GFR-0013 | — | — | — | P01563 | 188 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Interferon beta-1b (recombinant) | PRO-GFR-0014 | — | — | — | P01574 | 187 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Interferon gamma (human, recombinant) | PRO-GFR-0015 | — | — | — | P01579 | 166 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Interleukin-1 beta (human, recombinant) | PRO-GFR-0016 | — | — | — | P01584 | 269 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Interleukin-10 (human, recombinant) | PRO-GFR-0017 | — | — | — | P22301 | 178 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Interleukin-2 (human, recombinant) | PRO-GFR-0018 | — | — | — | P60568 | 153 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Interleukin-4 (human, recombinant) | PRO-GFR-0019 | — | — | — | P05112 | 153 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Interleukin-6 (human, recombinant) | PRO-GFR-0020 | — | — | — | P05231 | 212 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Keratinocyte growth factor (FGF-7, human) | PRO-GFR-0021 | — | — | — | O15520 | 208 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Nerve growth factor beta (human, recombinant) | PRO-GFR-0022 | — | — | — | P01138 | 241 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Osteogenic growth peptide | PEP-GFR-0004 | 132996-61-3 | C68H110N22O18 | 1523.7 | — | — | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Platelet-derived growth factor BB (human) | PRO-GFR-0023 | — | — | — | P01127 | 241 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| TB-500 | PEP-GFR-0005 | 885340-08-9 | C38H68N10O14 | 889.0 | — | — | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Thymosin alpha-1 | PEP-GFR-0006 | — | C129H215N33O55 | 3108.3 | — | — | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Thymosin beta-4 | PEP-GFR-0007 | — | C212H350N56O78S | 4963.0 | — | — | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Transforming growth factor alpha (human) | PEP-GFR-0008 | 105186-99-0 | C239H348N70O72S6 | 5546.0 | — | — | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| Tumour necrosis factor alpha (human, recombinant) | PRO-GFR-0024 | — | — | — | P01375 | 233 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
| VEGF-A165 (human, recombinant) | PRO-GFR-0025 | — | — | — | P15692-4 | 191 aa | Growth factors, cytokines and their fragments | Quotation on request | Request a quotation |
Neuropeptides and neuroendocrine fragments
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| Agouti-related protein (83-132) human | FRG-NEU-0001 | — | — | — | O00253 | 83-132 | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Alarin (human) | PEP-NEU-0001 | — | — | — | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| BAM-22P | PEP-NEU-0002 | 76622-26-9 | C130H184N38O31S2 | 2839.2 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Catestatin (human) | PEP-NEU-0003 | — | C104H164N32O27S | 2326.7 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Chromogranin A (human) fragment WE-14 | PEP-NEU-0004 | — | C72H116N18O24S | 1649.9 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Cocaine- and amphetamine-regulated transcript (55-102) human | FRG-NEU-0002 | — | — | — | Q16568 | 55-102 | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Cocaine- and amphetamine-regulated transcript (62-102) | FRG-NEU-0003 | — | — | — | Q16568 | 62-102 | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Cortistatin-14 (human) | FRG-NEU-0004 | — | — | — | O00230 | 92-105 | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Cortistatin-17 (human) | PEP-NEU-0005 | — | C96H139N27O24S3 | 2151.5 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Galanin (1-19) human | FRG-NEU-0005 | — | — | — | P22466 | precursor 33-51 (Galanin residues 1-19) | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Galanin (1-30) human | PEP-NEU-0006 | 119418-04-1 | C139H210N42O43 | 3157.4 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Galanin-like peptide (human) | FRG-NEU-0006 | — | — | — | Q9UBC7 | 25-84 | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Humanin | PEP-NEU-0007 | 330936-69-1 | C119H204N34O32S2 | 2687.3 | — | — | Neuropeptides and neuroendocrine fragments | In stock | Request a quotation |
| Myelin basic protein (85-99) | PEP-NEU-0008 | 444305-16-2 | C70H114N18O21 | 1543.8 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| N-Acetyl semax amidate | PEP-NEU-0009 | 2920938-90-3 | C39H54N10O10S | 855.0 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Nesfatin-1 (human) | FRG-NEU-0007 | — | — | — | P80303 | 25-106 | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Neuropeptide B-29 (human) | FRG-NEU-0008 | — | — | — | Q8NG41 | 25-53 | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Neuropeptide W-23 (human) | FRG-NEU-0009 | — | — | — | Q8N729 | 33-55 | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Neuropeptide Y (human) | FRG-NEU-0010 | — | — | — | P01303 | 29-64 | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Nocistatin (human) | PEP-NEU-0010 | 212609-11-5 | C149H238N42O53S3 | 3561.9 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) | PEP-NEU-0011 | 157115-85-0 | C17H22N2O4 | 318.4 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Orexin A (human) | PEP-NEU-0012 | — | C152H243N47O44S4 | 3561.1 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Orexin B (human) | PEP-NEU-0013 | 205640-91-1 | C123H212N44O35S | 2899.3 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Phoenixin-14 | PEP-NEU-0014 | 1415039-79-0 | C75H110N18O20 | 1583.8 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Phoenixin-20 | PEP-NEU-0015 | 1415039-77-8 | C101H153N25O29 | 2181.4 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Pituitary adenylate cyclase-activating peptide (1-27) | PEP-NEU-0016 | 127317-03-7 | C142H224N40O39S | 3147.6 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Pituitary adenylate cyclase-activating peptide (1-38) | PEP-NEU-0017 | — | C203H331N63O53S | 4534.0 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Secretoneurin (human) | FRG-NEU-0011 | — | — | — | P13521 | 182-214 | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Selank | PEP-NEU-0018 | 129954-34-3 | C33H57N11O9 | 751.9 | — | — | Neuropeptides and neuroendocrine fragments | In stock | Request a quotation |
| Spexin | PEP-NEU-0019 | 1370290-58-6 | C74H114N20O19S | 1619.9 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
| Vasoactive intestinal peptide (human) | PEP-NEU-0020 | 37221-79-7 | C147H237N43O43S | 3326.8 | — | — | Neuropeptides and neuroendocrine fragments | Quotation on request | Request a quotation |
Epitope tags, purification tags and cleavage-site peptides
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| ALFA-tag peptide | PEP-TAG-0001 | 2413353-86-1 | C69H123N25O24 | 1686.9 | — | — | Epitope tags, purification tags and cleavage-site peptides | Quotation on request | Request a quotation |
| c-Myc tag peptide (EQKLISEEDL) | PEP-TAG-0002 | — | C51H86N12O21 | 1203.3 | — | — | Epitope tags, purification tags and cleavage-site peptides | Quotation on request | Request a quotation |
| FLAG peptide (DYKDDDDK) | PEP-TAG-0003 | 98849-88-8 | C41H60N10O20 | 1013.0 | — | — | Epitope tags, purification tags and cleavage-site peptides | Quotation on request | Request a quotation |
| HA tag peptide (YPYDVPDYA) | PEP-TAG-0004 | 92000-76-5 | C53H67N9O17 | 1102.1 | — | — | Epitope tags, purification tags and cleavage-site peptides | Quotation on request | Request a quotation |
| S-tag peptide | PEP-TAG-0005 | 7429-70-1 | C73H117N23O25S | 1748.9 | — | — | Epitope tags, purification tags and cleavage-site peptides | Quotation on request | Request a quotation |
| Sortase A (recombinant) | PRO-TAG-0001 | — | — | — | Q2FV99 | 206 aa | Epitope tags, purification tags and cleavage-site peptides | Quotation on request | Request a quotation |
| T7 tag peptide | PEP-TAG-0006 | 245445-88-9 | C41H71N13O16S3 | 1098.3 | — | — | Epitope tags, purification tags and cleavage-site peptides | Quotation on request | Request a quotation |
| TEV protease (recombinant) | FRG-TAG-0001 | — | — | — | P04517 | 2038-2279 | Epitope tags, purification tags and cleavage-site peptides | Quotation on request | Request a quotation |
| VSV-G tag peptide | PEP-TAG-0007 | 103425-05-4 | C57H94N16O19S | 1339.5 | — | — | Epitope tags, purification tags and cleavage-site peptides | Quotation on request | Request a quotation |
Research proteins, enzymes and domains
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| Alkaline phosphatase (calf intestinal) | PRO-PRO-0001 | — | — | — | P19111 | 533 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Alpha-chymotrypsin (bovine) | PRO-PRO-0002 | — | — | — | P00766 | 245 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Avidin (egg white) | PRO-PRO-0003 | — | — | — | P02701 | 152 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Beta-galactosidase (E. coli, recombinant) | PRO-PRO-0004 | — | — | — | P00722 | 1024 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Bovine serum albumin | PRO-PRO-0005 | — | — | — | P02769 | 607 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Calmodulin (human, recombinant) | PRO-PRO-0006 | — | — | — | P0DP23 | 149 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Carbonic anhydrase II (human, recombinant) | PRO-PRO-0007 | — | — | — | P00918 | 260 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Casein (bovine) | PRO-PRO-0008 | — | — | — | P02662 | 214 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Catalase (bovine liver) | PRO-PRO-0009 | — | — | — | P00432 | 527 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Cytochrome c (equine heart) | PRO-PRO-0010 | — | — | — | P00004 | 105 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Deoxyribonuclease I (bovine) | PRO-PRO-0011 | — | — | — | P00639 | 282 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Enterokinase light chain (recombinant) | FRG-PRO-0001 | — | — | — | P98073 | 785-1019 | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Factor Xa (bovine) | PRO-PRO-0012 | — | — | — | P00743 | 492 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Firefly luciferase (recombinant) | PRO-PRO-0013 | — | — | — | P08659 | 550 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Glutathione S-transferase (recombinant) | PRO-PRO-0014 | — | — | — | P08515 | 218 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Green fluorescent protein (recombinant) | PRO-PRO-0015 | — | — | — | P42212 | 238 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Hen egg lysozyme (46-61) | FRG-PRO-0002 | — | — | — | P00698 | 46-61 | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Horseradish peroxidase | PRO-PRO-0016 | — | — | — | P00433 | 353 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| HRV 3C protease (recombinant) | FRG-PRO-0003 | — | — | — | P04936 | 1508-1690 | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Human albumin (recombinant) | PRO-PRO-0017 | — | — | — | P02768 | 609 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Lactoferrin (human, recombinant) | PRO-PRO-0018 | — | — | — | P02788 | 710 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Leukaemia inhibitory factor (human, recombinant) | PRO-PRO-0019 | — | — | — | P15018 | 202 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Lysozyme (hen egg white) | PRO-PRO-0020 | — | — | — | P00698 | 147 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Myoglobin (equine) | PRO-PRO-0021 | — | — | — | P68082 | 154 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Myostatin (GDF-8) propeptide | PRO-PRO-0022 | — | — | — | O14793 | 375 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| NEDD8 (human, recombinant) | PRO-PRO-0023 | — | — | — | Q15843 | 81 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Neurotrophin-3 (human, recombinant) | PRO-PRO-0024 | — | — | — | P20783 | 257 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Neurotrophin-4 (human, recombinant) | PRO-PRO-0025 | — | — | — | P34130 | 210 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Osteocalcin (human) | PRO-PRO-0026 | — | — | — | P02818 | 100 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Papain | PRO-PRO-0027 | — | — | — | P00784 | 345 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Prokineticin-2 (human, recombinant) | PRO-PRO-0028 | — | — | — | Q9HC23 | 129 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Protein A (recombinant) | PRO-PRO-0029 | — | — | — | P38507 | 508 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Protein G (recombinant) | PRO-PRO-0030 | — | — | — | P06654 | 448 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Protein L (recombinant) | PRO-PRO-0031 | — | — | — | Q51911 | 387 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Proteinase K | PRO-PRO-0032 | — | — | — | P06873 | 384 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Renilla luciferase (recombinant) | PRO-PRO-0033 | — | — | — | P27652 | 311 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Resistin (human, recombinant) | PRO-PRO-0034 | — | — | — | Q9HD89 | 108 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Ribonuclease A (bovine pancreas) | PRO-PRO-0035 | — | — | — | P61823 | 150 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Stem cell factor (human, recombinant) | PRO-PRO-0036 | — | — | — | P21583 | 273 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Streptavidin (recombinant) | PRO-PRO-0037 | — | — | — | P22629 | 183 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Subtilisin | PEP-PRO-0001 | — | C45H68N10O15 | 989.1 | — | — | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| SUMO protease Ulp1 (recombinant) | PRO-PRO-0038 | — | — | — | Q02724 | 621 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| SUMO-1 (human, recombinant) | PRO-PRO-0039 | — | — | — | P63165 | 101 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Superoxide dismutase 1 (human, recombinant) | PRO-PRO-0040 | — | — | — | P00441 | 154 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Thermolysin | PRO-PRO-0041 | — | — | — | P00800 | 548 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Thrombin (human, recombinant) | PRO-PRO-0042 | — | — | — | P00734 | 622 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Thrombospondin-1 peptide (ABT-510) | PRO-PRO-0043 | — | — | — | P07996 | 1170 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Transferrin (human) | PRO-PRO-0044 | — | — | — | P02787 | 698 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Trypsin (bovine, sequencing grade) | PRO-PRO-0045 | — | — | — | P00760 | 246 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Ubiquitin (human, recombinant) | PRO-PRO-0046 | — | — | — | P0CG47 | 229 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
| Visfatin (human, recombinant) | PRO-PRO-0047 | — | — | — | P43490 | 491 aa | Research proteins, enzymes and domains | Quotation on request | Request a quotation |
Opioid peptides
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| alpha-Neoendorphin | PEP-OPI-0001 | 69671-17-6 | C60H89N15O13 | 1228.4 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| beta-Casomorphin-7 (bovine) | PEP-OPI-0002 | 72122-62-4 | C41H55N7O9 | 789.9 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| beta-Endorphin (human) | PEP-OPI-0003 | — | C158H251N39O46S | 3465.0 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Big dynorphin | PEP-OPI-0004 | — | C185H292N58O41 | 3985.0 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| CTAP | PEP-OPI-0005 | 103429-32-9 | C51H69N13O11S2 | 1104.3 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| CTOP | PEP-OPI-0006 | 103429-31-8 | C50H67N11O11S2 | 1062.3 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| DADLE | PEP-OPI-0007 | 63631-40-3 | C29H39N5O7 | 569.6 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| DAMGO | PEP-OPI-0008 | 78123-71-4 | C26H35N5O6 | 513.6 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Deltorphin I | PEP-OPI-0009 | 122752-15-2 | C37H52N8O10 | 768.9 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Deltorphin II | PEP-OPI-0010 | — | C38H54N8O10 | 782.9 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Dermorphin | PEP-OPI-0011 | 77614-16-5 | C40H50N8O10 | 802.9 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| DPDPE | PEP-OPI-0012 | 88373-73-3 | C30H39N5O7S2 | 645.8 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| DSLET | PEP-OPI-0013 | 75644-90-5 | C33H46N6O10 | 686.8 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Dynorphin A (1-13) | PEP-OPI-0014 | 72957-38-1 | C75H126N24O15 | 1604.0 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Dynorphin A (1-17) | PEP-OPI-0015 | 80448-90-4 | C99H155N31O23 | 2147.5 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Dynorphin A (1-8) | PEP-OPI-0016 | 75790-53-3 | C46H72N14O10 | 981.2 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Dynorphin B | PEP-OPI-0017 | — | C74H115N21O17 | 1570.8 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Endomorphin-1 | PEP-OPI-0018 | 189388-22-5 | C34H38N6O5 | 610.7 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Endomorphin-2 | PEP-OPI-0019 | 141801-26-5 | C32H37N5O5 | 571.7 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Hemorphin-7 | PEP-OPI-0020 | 152685-85-3 | C49H64N12O11 | 997.1 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Leu-enkephalin | PEP-OPI-0021 | — | C28H37N5O7 | 555.6 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Leucine-enkephalin amide | PEP-OPI-0022 | — | C28H38N6O6 | 554.6 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Met-enkephalin | PEP-OPI-0023 | — | C27H35N5O7S | 573.7 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Met-enkephalin-Arg-Phe | PEP-OPI-0024 | 73024-95-0 | C42H56N10O9S | 877.0 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Morphiceptin | PEP-OPI-0025 | 74135-04-9 | C28H35N5O5 | 521.6 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Nociceptin (orphanin FQ) | PEP-OPI-0026 | 170713-75-4 | C79H129N27O22 | 1809.0 | — | — | Opioid peptides | Quotation on request | Request a quotation |
| Valorphin | PEP-OPI-0027 | — | C44H60N8O12 | 893.0 | — | — | Opioid peptides | Quotation on request | Request a quotation |
Amyloid, aggregation and model peptides
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| Alpha-synuclein (1-140) recombinant | PRO-AMY-0001 | — | — | — | P37840 | 140 aa | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Alpha-synuclein NAC (61-95) | FRG-AMY-0001 | — | — | — | P37840 | 61-95 | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Amyloid beta (1-16) human | FRG-AMY-0002 | — | — | — | P05067 | 1-16 | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Amyloid beta (1-28) human | FRG-AMY-0003 | — | — | — | P05067 | 1-28 | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Amyloid beta (1-40) human | FRG-AMY-0004 | — | — | — | P05067 | 1-40 | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Amyloid beta (1-42) human | FRG-AMY-0005 | — | — | — | P05067 | 1-42 | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Amyloid beta (16-22) KLVFFAE | PEP-AMY-0001 | 153247-41-7 | C43H64N8O10 | 853.0 | — | — | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Amyloid beta (17-42) p3 | FRG-AMY-0006 | — | — | — | P05067 | 17-42 | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Amyloid beta (25-35) | PEP-AMY-0002 | 155178-13-5 | C119H194N28O33S | 2577.0 | — | — | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Islet amyloid polypeptide (20-29) human | FRG-AMY-0007 | — | — | — | P10997 | 20-29 | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Prion protein fragment (106-126) human | FRG-AMY-0008 | — | — | — | Q9UKY0 | 106-126 | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Prion protein fragment (118-135) human | FRG-AMY-0009 | — | — | — | Q9UKY0 | 118-135 | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
| Tau (273-284) | PEP-AMY-0003 | — | — | — | — | — | Amyloid, aggregation and model peptides | Quotation on request | Request a quotation |
Antimicrobial and host-defence peptides
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apidaecin IB | PEP-AMP-0001 | 123997-21-7 | C95H150N32O23 | 2108.4 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Aurein 1.2 | PEP-AMP-0002 | 302343-01-7 | C71H114N16O18 | 1479.8 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Bacitracin | PEP-AMP-0003 | 1405-87-4 | C66H103N17O16S | 1422.7 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Bactenecin | PEP-AMP-0004 | 116229-36-8 | C63H118N24O13S2 | 1483.9 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Brevinin-1 | PEP-AMP-0005 | — | C121H202N28O26S2 | 2529.2 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Buforin II | PEP-AMP-0006 | — | C106H184N40O26 | 2434.8 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Cecropin A | PEP-AMP-0007 | 80451-04-3 | C184H313N53O46 | 4004.0 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Cecropin B | PEP-AMP-0008 | 80451-05-4 | C176H302N52O41S | 3835.0 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Cecropin P1 | PEP-AMP-0009 | 125667-96-1 | C147H253N45O43 | 3338.9 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Citropin 1.1 | PEP-AMP-0010 | — | C76H131N19O19 | 1615.0 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Clavanin A | PEP-AMP-0011 | — | C131H185N35O26 | 2666.1 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Colistin | PEP-AMP-0012 | 1066-17-7 | C52H98N16O13 | 1155.4 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Daptomycin | PEP-AMP-0013 | 103060-53-3 | C72H101N17O26 | 1620.7 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Dermaseptin S1 | PEP-AMP-0014 | — | C152H257N43O44S2 | 3455.1 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Drosocin | PEP-AMP-0015 | 149924-99-2 | C98H160N34O24 | 2198.5 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Esculentin-1a (1-21) | PEP-AMP-0016 | 131889-89-9 | C42H68O17 | 845.0 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Gramicidin S | PEP-AMP-0017 | 113-73-5 | C60H92N12O10 | 1141.4 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Hepcidin-20 (human) | FRG-AMP-0001 | — | — | — | P81172 | 65-84 | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Hepcidin-25 (human) | PEP-AMP-0018 | — | C113H170N34O31S9 | 2789.4 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Histatin 5 | PEP-AMP-0019 | 104339-66-4 | C133H195N51O33 | 3036.3 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Human beta-defensin 1 | FRG-AMP-0002 | — | — | — | P60022 | 33-68 | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Human beta-defensin 2 | PEP-AMP-0020 | 372146-20-8 | C190H306F3N55O52S6 | 4442.0 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Human beta-defensin 3 | FRG-AMP-0003 | — | — | — | P81534 | 23-67 | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Human beta-defensin 4 | FRG-AMP-0004 | — | — | — | Q8WTQ1 | 23-72 | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Human defensin 5 (HD-5) | FRG-AMP-0005 | — | — | — | Q01523 | 20-94 | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Human defensin 6 (HD-6) | FRG-AMP-0006 | — | — | — | Q01524 | 69-100 | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Human neutrophil peptide 1 (HNP-1) | FRG-AMP-0007 | — | — | — | P59665 | 65-94 | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Human neutrophil peptide 2 (HNP-2) | FRG-AMP-0008 | — | — | — | P59665 | 66-94 | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Human neutrophil peptide 3 (HNP-3) | FRG-AMP-0009 | — | — | — | P59666 | 65-94 | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Human neutrophil peptide 4 (HNP-4) | PEP-AMP-0021 | — | C157H255N49O43S6 | 3709.4 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| IDR-1018 | PEP-AMP-0022 | 1453221-07-2 | C71H126N26O12 | 1535.9 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Indolicidin | PEP-AMP-0023 | 140896-21-5 | C100H132N26O13 | 1906.3 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| KR-12 | PEP-AMP-0024 | 2022956-47-2 | C81H140N26O18S | 1798.2 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Lactoferricin B | PEP-AMP-0025 | — | C141H226N46O29S3 | 3125.8 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Lactoferricin H (human) | FRG-AMP-0010 | — | — | — | P02788 | 20-67 | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| LEAP-2 (human) | FRG-AMP-0011 | — | — | — | Q969E1 | 38-77 | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| LL-37 | PEP-AMP-0026 | 154947-66-7 | C205H340N60O53 | 4493.3 | — | — | Antimicrobial and host-defence peptides | In stock | Request a quotation |
| Maculatin 1.1 | PEP-AMP-0027 | — | C103H161N27O23 | 2145.5 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Magainin 1 | PEP-AMP-0028 | — | C112H177N29O28S | 2409.8 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Magainin 2 | PEP-AMP-0029 | 108433-95-0 | C114H180N30O29S | 2466.9 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Nisin A | PEP-AMP-0030 | 1414-45-5 | C143H230N42O37S7 | 3354.1 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Novispirin G10 | PEP-AMP-0031 | 384340-80-1 | C101H180N34O21 | 2206.7 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Omiganan | PEP-AMP-0032 | 204248-78-2 | C90H127N27O12 | 1779.1 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Oncocin | PEP-AMP-0033 | 1235497-90-1 | C109H177N37O24 | 2389.8 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Ovispirin-1 | PEP-AMP-0034 | 326855-45-2 | C105H188N34O21 | 2262.8 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Pexiganan (MSI-78) | PEP-AMP-0035 | 147664-63-9 | C122H210N32O22 | 2477.2 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| PGLa | PEP-AMP-0036 | 102068-15-5 | C88H162N26O22S | 1968.5 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Pleurocidin | PEP-AMP-0037 | 190324-47-1 | C129H192N36O29 | 2711.1 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Polymyxin B | PEP-AMP-0038 | 2220175-42-6 | C53H79F15N14O21 | 1533.3 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| PR-39 | PEP-AMP-0039 | 139637-11-9 | C229H345N69O41 | 4721.0 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Protegrin-1 | PEP-AMP-0040 | 168831-77-4 | C88H147N37O19S4 | 2155.6 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Pyrrhocoricin | PEP-AMP-0041 | 156548-23-1 | C113H179N33O34 | 2543.8 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Ranalexin | PEP-AMP-0042 | 155761-99-2 | C97H167N23O22S3 | 2103.7 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Rhesus theta-defensin 1 (RTD-1) | PEP-AMP-0043 | 251442-64-5 | C82H137N33O19S6 | 2081.6 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Tachyplesin I | PEP-AMP-0044 | — | C99H151N35O19S4 | 2263.8 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Temporin A | PEP-AMP-0045 | 188713-69-1 | C68H117N17O14 | 1396.8 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Temporin L | PEP-AMP-0046 | 188713-81-7 | C83H122N20O15 | 1640.0 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Thanatin | PEP-AMP-0047 | 214542-43-5 | C103H177N35O27S3 | 2433.9 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
| Tritrpticin | PEP-AMP-0048 | 179264-81-4 | C96H132N28O14 | 1902.3 | — | — | Antimicrobial and host-defence peptides | Quotation on request | Request a quotation |
Immunological epitope peptides
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| CMV pp65 (495-503) NLVPMVATV | FRG-IMM-0001 | — | — | — | P06725 | 495-503 | Immunological epitope peptides | Quotation on request | Request a quotation |
| EBV BMLF1 (280-288) GLCTLVAML | FRG-IMM-0002 | — | — | — | A0A0F6QJ07 | 259-267 | Immunological epitope peptides | Quotation on request | Request a quotation |
| gp100 (209-217) | PEP-IMM-0001 | — | C46H72N10O15 | 1005.1 | — | — | Immunological epitope peptides | Quotation on request | Request a quotation |
| HIV-1 gag (77-85) SLYNTVATL | FRG-IMM-0003 | — | — | — | P04591 | 77-85 | Immunological epitope peptides | Quotation on request | Request a quotation |
| Influenza A NP (366-374) | PEP-IMM-0002 | 145253-17-4 | C36H59N11O17S2 | 982.1 | — | — | Immunological epitope peptides | Quotation on request | Request a quotation |
| MART-1 (26-35) | FRG-IMM-0004 | — | — | — | Q16655 | 26-35 | Immunological epitope peptides | Quotation on request | Request a quotation |
| MOG (35-55) | FRG-IMM-0005 | — | — | — | Q61885 | 35-55 (mature-chain numbering, i.e. numbering after the 28-residue signal peptide; UniProt precursor positions 63-83) | Immunological epitope peptides | Quotation on request | Request a quotation |
| Ovalbumin (257-264) SIINFEKL | PEP-IMM-0003 | — | C45H74N10O13 | 963.1 | — | — | Immunological epitope peptides | Quotation on request | Request a quotation |
| Ovalbumin (323-339) | PEP-IMM-0004 | 92915-79-2 | C74H120N26O25 | 1773.9 | — | — | Immunological epitope peptides | Quotation on request | Request a quotation |
| PADRE peptide | PEP-IMM-0005 | 161147-59-7 | C65H102N16O15 | 1347.6 | — | — | Immunological epitope peptides | Quotation on request | Request a quotation |
| PLP (139-151) | PEP-IMM-0006 | 131334-43-5 | C72H104N20O16S | 1537.8 | — | — | Immunological epitope peptides | Quotation on request | Request a quotation |
| Rigin | PEP-IMM-0007 | 77727-17-4 | C18H32N8O6 | 456.5 | — | — | Immunological epitope peptides | Quotation on request | Request a quotation |
| Splenopentin | PEP-IMM-0008 | 75957-60-7 | C31H51N9O9 | 693.8 | — | — | Immunological epitope peptides | Quotation on request | Request a quotation |
| Thymogen (Glu-Trp) | PEP-IMM-0009 | 38101-59-6 | C16H19N3O5 | 333.3 | — | — | Immunological epitope peptides | Quotation on request | Request a quotation |
| Thymopentin | PEP-IMM-0010 | 69558-55-0 | C30H49N9O9 | 679.8 | — | — | Immunological epitope peptides | Quotation on request | Request a quotation |
| Tuftsin | PEP-IMM-0011 | — | C21H40N8O6 | 500.6 | — | — | Immunological epitope peptides | Quotation on request | Request a quotation |
| Universal T-helper epitope P30 | FRG-IMM-0006 | — | — | — | P04958 | 947-967 | Immunological epitope peptides | Quotation on request | Request a quotation |
Collagen, matrix and adhesion peptides
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| Collagen II (259-273) | FRG-MTX-0001 | — | — | — | P02458 | 259-273 | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| Collagen type I (bovine) | PRO-MTX-0001 | — | — | — | P02453 | 1463 aa | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| Collagen type I fragment peptide | PRO-MTX-0002 | — | — | — | P02452 | 1464 aa | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| Eptifibatide | PEP-MTX-0001 | — | C35H49N11O9S2 | 832.0 | — | — | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| Fibronectin (human) | PRO-MTX-0003 | — | — | — | P02751 | 2477 aa | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| Fibronectin CS1 peptide | PEP-MTX-0002 | 136466-51-8 | C38H64N8O15 | 873.0 | — | — | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| GRGDS | PEP-MTX-0003 | 96426-21-0 | C17H30N8O9 | 490.5 | — | — | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| GRGDSP | PEP-MTX-0004 | — | C22H37N9O10 | 587.6 | — | — | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| IKVAV laminin peptide | PEP-MTX-0005 | 131167-89-0 | C25H48N6O6 | 528.7 | — | — | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| iRGD (CRGDKGPDC) | PEP-MTX-0006 | — | C35H57N13O14S2 | 948.0 | — | — | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| Irisin (human, recombinant) | FRG-MTX-0002 | — | — | — | Q8NAU1 | 1-191 | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| RGDS peptide | PEP-MTX-0007 | 91037-65-9 | C15H27N7O8 | 433.4 | — | — | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| VGVAPG elastin-derived peptide | PEP-MTX-0008 | 92899-39-3 | C22H38N6O7 | 498.6 | — | — | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
| YIGSR laminin peptide | PEP-MTX-0009 | 110590-64-2 | C26H42N8O8 | 594.7 | — | — | Collagen, matrix and adhesion peptides | Quotation on request | Request a quotation |
Cell-penetrating and delivery peptides
| Material | Catalog ID | CAS No. | Molecular formula | Molecular weight | UniProt Accession | Residue range / Length | Molecular class | Availability | Action |
|---|---|---|---|---|---|---|---|---|---|
| GALA peptide | PEP-CPP-0001 | 107658-43-5 | C136H215N33O45 | 3032.4 | — | — | Cell-penetrating and delivery peptides | Quotation on request | Request a quotation |
| gH625 | PEP-CPP-0002 | — | C106H161N33O25 | 2297.6 | — | — | Cell-penetrating and delivery peptides | Quotation on request | Request a quotation |
| KALA peptide | PEP-CPP-0003 | 187987-64-0 | C144H248N40O35S | 3131.8 | — | — | Cell-penetrating and delivery peptides | Quotation on request | Request a quotation |
| Nonaarginine (R9) | PEP-CPP-0004 | 143413-47-2 | C54H110N36O10 | 1423.7 | — | — | Cell-penetrating and delivery peptides | Quotation on request | Request a quotation |
| Octaarginine (R8) | PEP-CPP-0005 | — | C50H99F3N32O11 | 1381.5 | — | — | Cell-penetrating and delivery peptides | Quotation on request | Request a quotation |
| Penetratin (Antennapedia 43-58) | PEP-CPP-0006 | 188842-14-0 | C104H169N35O19S | 2245.7 | — | — | Cell-penetrating and delivery peptides | Quotation on request | Request a quotation |
| pVEC | PEP-CPP-0007 | — | C98H177N37O21 | 2209.7 | — | — | Cell-penetrating and delivery peptides | Quotation on request | Request a quotation |
| SynB1 | PEP-CPP-0008 | 1207092-86-1 | C89H151N37O27 | 2171.4 | — | — | Cell-penetrating and delivery peptides | Quotation on request | Request a quotation |
| TAT (47-57) | PEP-CPP-0009 | 1231898-25-1 | C74H132N34O16S | 1786.1 | — | — | Cell-penetrating and delivery peptides | Quotation on request | Request a quotation |
| TAT (48-60) | PEP-CPP-0010 | 220408-24-2 | C70H131N35O16 | 1719.0 | — | — | Cell-penetrating and delivery peptides | Quotation on request | Request a quotation |
| VP22 (267-300) | PEP-CPP-0011 | 1932346-53-6 | C7H14O5 | 178.2 | — | — | Cell-penetrating and delivery peptides | Quotation on request | Request a quotation |
